Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART Pilot Study: Aspirin Resistance in Trinidad
NCT06228820Phase 2Completed
- Sponsor
- The University of the West Indies
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aspirin in cardiovascular diseases (CVD), sponsored by The University of the West Indies. Primary endpoint: Aspirin Resistance Unit at 2 weeks. Started Jan 2024; status: completed.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT06228820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06228820.